Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment study of binge eating disorder (BED) and its background factors
2010-019892-31Phase 2Completed
- Sponsor
- Opiant Pharmaceuticals
- Start
- May 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in binge eating disorder (BED) comparing Nasal naloxone with Placebo nasal spray (2 arms). Primary endpoint: Number of binge eating episodes. Started May 2011; status: completed.
02
Drugs
naloxone
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on 2010-019892-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019892-31.